Skip to content
Menu

Iovance Biotherapeutics, Inc. IOVA

Full chart Compare
Set alert

Price alert · IOVA

All alert types
6.90 USD -0.41 (-5.61%)

Regular-session close

6.98 +0.08 +1.16%

After hours · Nov 20, 7:32 PM ET

6.77 Day range 7.40
2.08 52-week range 15.37
YTD
+152.75%
1 year
+216.51%

Revenue & Expenses

Revenue by
Revenue Profit Costs
Other Income$5.16MIncome Tax Benefit$2.07MGross Profit$90.32MNet Loss$390.98MCost of Revenue$173.18MExpenses$488.53MSelling, General & Admin$152.32MResearch & Development$300.27MOther Operating Expenses$35.94MRevenue$263.50MUnited States$259.01MNon-US$4.49M

Latest period ending Dec 31, 2025 · select a line to chart its full history

IOVA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
263.50M164.07M1.19M00
90.32M70.82M156.00K00
-403.36M-395.28M-460.56M-398.88M-342.70M
-390.98M-372.18M-444.04M-395.89M-342.25M
-1.09-1.28-1.89-2.49-2.23
IOVA annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
169.06M122.05M181.32M238.16M84.31M
913.17M910.43M780.35M663.98M777.33M
214.59M200.02M195.74M164.34M155.67M
49.44M58.26M75.86M85.45M71.53M
698.58M710.40M584.61M499.64M621.66M
IOVA annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-302.41M-352.98M-361.82M-292.76M-227.94M
47.50M-96.41M-155.24M256.45M132.00K
300.77M390.66M462.96M190.15M239.27M
-33.84M-11.07M-22.29M-20.43M-37.57M
47.01M-59.27M-56.84M153.85M11.46M